Sensitivity of imatinib-resistant T315I BCR-ABL CML to a synergistic combination of ponatinib and forskolin treatment

por Oaxaca, Derrick M., Yang-Reid, Sun Ah, Ross, Jeremy A., Rodriguez, Georgialina, Staniswalis, Joan G., Kirken, Robert A.
Publicado 2016